Sentinel Node Biopsy and Neck Dissection for Cutaneous Head and Neck Malignant Melanoma (Part1: Sentinel Node Biopsy)

Bibliographic Information

Other Title
  • 頭頸部皮膚悪性黒色腫に対するセンチネルリンパ節生検及び頸部リンパ節郭清術についての検討(第一報:センチネルリンパ節生検について)
  • アタマ ケイブ ヒフ アクセイ コクショク シュ ニ タイスル センチネルリンパセツセイケンオヨビ ケイブ リンパセツカクセイジュツ ニ ツイテ ノ ケントウ(ダイイチポウ)センチネルリンパセツセイケン ニ ツイテ

Search this article

Abstract

Twenty four patients who underwent sentinel lymph node biopsy for cutaneous head and neck malignant melanoma in the Division of Dermatology, National Cancer Center Hospital from December 2002 to September 2010 were reviewed. The identification rate of sentinel lymph node biopsy was 100%. The number of identified lymph nodes ranged from 1-6 (average 2.9). Some of the cases included multiple sentinel lymph nodes. Parotid lymph nodes were observed in 16 (66.7%) out of all 24 cases. When a primary site was located on the middle of the face, the sentinel lymph node was identified in as high as 14 (93.3%) out of 15 cases. When the primary site was an occipital or parietal lesion, the sentinel lymph node was identified at level V in all cases. In addition, the superficial lymph nodes (superficial parotid lymph nodes/postauricular lymph nodes/superficial cervical lymph nodes) characteristic of a skin malignant tumor were identified in 9 (37.5%) out of 24 cases. In 8 (33.3%) of 24 cases, the sentinel lymph node results were positive, and all of them underwent selective neck dissection. The 5-year survival rate of all 24 patients was 86.5%.

Journal

Details 詳細情報について

Report a problem

Back to top